Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on June 18, 2024, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland. The invitation to the AGM with agenda items and explanations will be sent to registered shareholders by mail and can be viewed on Santhera’s website at https://www.santhera.com/share-bondholder-me
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 - Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 - Santhera Pharmaceuticals (SIX: SANN) announces the publication of its Annual Report 2023 with fully audited results
Santhera Publishes Annual Report 2023 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
The "Europe Constrained Peptide Drugs Market: Analysis and Forecast, 2024-2040" report has been added to ResearchAndMarkets.com's offering. The market size is anticipated to be $0.06 billion in 2026